Ubie, a NYC-based AI-driven and medically vetted healthcare prediction platform that guides sufferers to the care they want, introduced that its cumulative funding since founding in 2017 has reached over $125M.
Backers included Google, JAPAN POST CAPITAL Co., Ltd., NTT DOCOMO, INC., SEVEN-ELEVEN JAPAN CO., LTD., Japan Finance Company, and The Shoko Chukin Financial institution, Ltd.
Ubie beforehand introduced Collection C funding of $26.2M, with a cumulative whole of $59.8M in August 2022. Within the US, Ubie’s medically-validated AI Symptom Checker has pushed partnerships with key advocacy and life sciences firms. The variety of customers of Symptom Checker within the US lately reached over 4 million whole customers, with an 85% enhance of month-to-month natural customers since 2024.
Based in 2017, and led by Kota Kubo, CEO, Ubie empowers people and healthcare professionals with its free on-line Symptom Checker and equips 1,800+ supplier organizations with scientific instruments that streamline workflows and assist diagnoses and well being outcomes. Skilled on medical knowledge, Ubie’s advertising and marketing options energy superior focusing on capabilities and high-performing digital campaigns for 21 out of prime 30 world’s prime life science firms.
Ubie can be creating a supplier answer following its acceptance into the Mayo Clinic’s Platform Speed up program.
FinSMEs
26/06/2025
